학술논문
'학술논문'
에서 검색결과 60건 | 목록
1~10
Academic Journal
Freitas R; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Miranda A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal.; Castro F; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Ferreira E; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Gonçalves M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Eiras M; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Santos B; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; Immunology Department, Portuguese Oncology Institute of Porto (IPO-Porto), 4200-072 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal.; Correia MP; Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), 4200-072 Porto, Portugal.; Oliveira MJ; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal.; Sarmento B; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal / INEB - Institute for Biomedical Engineering, University of Porto, 4200-135 Porto, Portugal; IUCS-CESPU, 4585-116 Gandra, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; Health School of University Fernando Pessoa, 4249-004 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal; Department of Surgical Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Silva AMN; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto) / Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - Institute of Biomedical Sciences Abel Salazar, University of Porto, 4050-313 Porto, Portugal; GlycoMatters Biotech, 4500-162 Espinho, Portugal. Electronic address: jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE
MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.
Academic Journal
Santos DAR; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Santos M; School of Health, Polytechnic Institute of Porto, Rua Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.; Centro de Investigação em Saúde e Ambiente (CISA), Escola Superior de Saúde, Instituto Politécnico do Porto, 4200-072 Porto, Portugal.; Molecular Oncology & Viral Pathology, IPO-Porto Research Center (CI-IPO), Portuguese Institute of Oncology, 4200-072 Porto, Portugal.; Santos L; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology (IPO-Porto), 4200-072 Porto, Portugal.; Dinis-Ribeiro M; Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP), Rise@CI-IPOP (Health Research Group), Portuguese Institute of Oncology of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.; Department of Gastroenterology, Portuguese Oncology Institute of Porto, 4200-072 Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Research Center of IPO Porto (CI-IPOP), RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Center (Porto.CCC), 4200-072 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Academic Journal
Costa C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Pereira S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; ICBAS, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Nucleo de Investigação e Informação em Farmácia - Centro de Investigação em Saúde e Ambiente (CISA), School of Allied Health Sciences - Polytechnic Institute of Oporto, Porto, Portugal.; Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP), Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Neves D; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Neves M; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Tavares A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Department of Pathology, Portuguese Institute of Oncology, Porto, Portugal.; Gil da Costa RM; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Faculty of Engineering, Laboratory for Process, Environment, Biotechnology and Energy Engineering (LEPABE), University of Porto, Porto, Portugal.; Cruz R; Department of Urology, Portuguese Institute of Oncology, Porto, Portugal.; Amaro T; Department of Urology, Hospital Pedro Hispano, Matosinhos, Portugal.; Oliveira PA; Department of Veterinary Sciences, CITAB, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Mass Spectrometry Center of the University of Aveiro, Campus de Santiago, Aveiro, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, Porto, Portugal.; Health Sciences Faculty of University Fernando Pessoa, Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology, Porto, Portugal.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Gaiteiro C; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Soares J; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Paulo P; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Brandão A; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Cancer Genetics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; Azevedo R; Laboratoire d'Etude du Métabolisme des Médicaments (LEMM), CEA, INRA, Université Paris Saclay, F-91191, Gif-sur-Yvette cedex, France.; Palmeira C; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; Immunology Department, Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135 Porto, Portugal.; Miranda A; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Osório H; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Ipatimup-Institute of Molecular Pathology and Immunology of the University of Porto, University of Porto, 4200-135 Porto, Portugal.; Prieto J; Center for Applied Medical Research (Centro de Investigación Médica Aplicada, CIMA), University of Navarra, 31008 Pamplona, Navarra, Spain.; Lima L; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; FP-I3ID, University Fernando Pessoa, 4249-004 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.; Department of Surgical Oncology, Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute (IPO Porto), 4200-072 Porto, Portugal.; RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.; GlycoMatters Biotech, 4500-162 Espinho, Portugal.
Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE
Academic Journal
Moler, Frank W.; Silverstein, Faye S.; Nadkarni, Vinay M.; Meert, Kathleen L.; Shah, Samir H.; Slomine, Beth; Christensen, James; Holubkov, Richard; Page, Kent; Dean, J. Michael; Alten, J.; Borasino, S.; Pruitt, C.; Bush, R.; Hock, K.; Dure, L.; Marullo, D.; Sanders, R.; Prodhan, P.; Hefley, G.; Dalton, H.; Buttram, S.; Wai, K.; La Bell, A.; Bliss, C.; Liss, D.; Ortiz, A.; Downhour, C.; Williams, K.; Lavoie, M.; Bordes-Edgar, V.; Theodorou, A.; Typpo, K.; Wells, C.; Deschenes, J.; Teodori, J.; Viscusi, C.; Katsanis, J.; Newth, C.; Rubin, S.; Bart, R.; Deakers, T.; Ghuman, A.; Khemani, R.; Markovitz, B.; Dicarlo, J.; Ross, P.; Wang, V.; Villa, M.; Fajardo, F.; Kwok, J.; Serrano, J.; Valentine, J.; Terry, J.; Yamakawa, A.; Briones, S.; Cauley, S.; Briseno, A.; Young, C.; Nyc, M.; Rosser, T.; Gold, J.; Engilman, R.; Schwarz, A.; Haykawa, J.; Patterson, T.; Vargas-Shiraishi, O.; Galion, A.; Armstrong, P.; Mathur, M.; Oei, G.; Barcega, B.; Newcombe, J.; Pinto, A.; Ashwal, S.; Michelson, D.; Pivonka-Jones, J.; Harrison, R.; Kelly, R.; Madikians, A.; Federman, M.; Morgan, M.; McQuillen, P.; Tabbutt, S.; Haeusslein, L.; Strong, S.; Glass, H.; Johnson, B.; Loomis, B.; Gano, D.; Hutchison, J.; Schwartz, S.; Guerguerian, A.; Boutis, K.; Clark, D.; Van Huyse, J.; Fusco, K.; McBain, K.; Kravecevic, A.; Toller, L.; Gaiteiro, R.; Furness, S.; Askaland, R.; Hahn, C.; Sananes, R.; Dobyns, E.; Rappaport, L.; Jewett, E.; Wilson, T.; Wathen, B.; Dix, M.; Allen, J.; Garling, T.; DiDomenico, D.; Loyola, D.; Bernard, T.; Dise-Lewis, J.; Stock, A.; Battick, K.; Fleming, A.; Hanson, J.; Macogay, M.; Martin, K.; Burger, K.; Pham, N.; Walson, K.; Sturm, J.; Stone, C.; Wellons, A.; Meisner, S.; Weissman, B.; Alexander, A.; Johnson, A.; Goodman, D.; Smith, C.; Powell, E.; Shah, S.; Chiambrietti, J.; Lutz, C.; Vitt, C.; Jackson-McCarthy, L.; Leannais, N.; Wainwright, M.; Goldstein, J.; Weil, C.; Porter, M.; Sullivan, J.; Orman, K.; Owen, E.; Hardin, A.; Potter, K.; Peterson, E.; Ruppe, M.; Berkenbosch, J.; Padmanabhan, P.; McDonald, M.; Montgomery, V.; Calhoun, A.; Thomas, M.; Michael, A.; Schanie, C.; Rayborn, L.; Kernen, K.; Bratton, T.; Good, L.; Puri, V.; Sears, L.; Bhalala, U.; Summers, J. Lee; Bembea, M.; Shaffner, D.; Walker, A.; Shackelford, M.; Larson, A.; Jamrogowicz, J.; Kim, J.; Felling, R.; Slomine, B.; Christensen, J. R.; Slomine, B. S.; DeMatt, E.; Talley, M.; Rodweller, C.; Meert, K.; Heidemann, S.; Clark, J.; Pawluszka, A.; Lulic, M.; Frey, M.; Sivaswamy, L.; Horman, S.; Chiodo, L.; Moler, F.; Stanley, R.; Cornell, T.; Weber, M.; Reske, J.; Conlin, L.; Silverstein, F.; Carlson, M.; Warschausky, S.; Behnke, T.; Poszywak, D.; Nowak, J.; Ortega, H.; Milner, D.; Zielinski, E.; Doucette, A.; Overman, A.; Leonard, C.; Gilles, E.; Huszar, P.; Troy, M.; Alden, J.; Pineda, J.; Oren, P.; Shoykhet, M.; Friess, S.; Guilliams, K.; Jaffe, D.; Day, T.; Hicks, T.; Barganier, L.; Fish, E.; Toennies, L.; Thurst, P.; Blankenship, S.; Noetzel, M.; White, D.; Schleien, C.; Cappell, J.; Schnadower, David; Talathoti, N.; Sidhu, N.; Hinton, V.; van der Jagt, E.; Taillie, E. R.; Nazarian, E.; Daugherty, L. E.; Davis, C. O.; Mulbury, J.; Kwon, J.; Adams, H.; Ofori-Amanfo, G.; Bordley, W.; Wrenn, S.; Uhl, T.; Milleson, C.; Smith, E.; Gustafson, K.; Asbeck, S.; Gallentine, W.; Lloyd, E.; Hall, M.; Khan, N.; Frazier, J.; Cohen, Daniel; Haines, J.; Carter, K.; Bird, L.; Hough, S.; Lo, W.; Yeates, K.; Morfing, K.; Ginn, M.; Wheeler, D.; Geis, G.; Beckman, E.; Banschbach, S.; Monaco, M.; Hallinan, B.; Walz, N.; Lidsky, K.; Bergant, S.; Browning, A.; Haky, J.; Bass, N.; Tangen, R.; Thomas, N.; Shelly, A.; Vallati, J.; Carper, P.; Spear, D.; McMonagle, A.; Stokes, J.; Watts, H.; Trescher, W.; Flaherty-Craig, C.; Topjian, A.; Berg, B.; Nadkarni, V.; Fitzgerald, J.; Meaney, P.; Alpern, E.; DiLiberto, M.; Twelves, C.; McGowan, S.; Sisko, M.; Park, B.; Ichord, R.; Radcliffe, J.; Thomas, N. Hattiangadi; Friedman, K.; Sullivan, A.; Fink, E.; Hickey, R.; Clark, R.; Bell, M.; Abraham, A.; Bell, R.; Varma, R.; Beers, S.; Feldman, H.; Walters, J.; McIntyre, K.; Anand, K.; Woodward, C.; Hickerson, A.; Moore, B.; West, A. Nico; Grandberry, M.; Shah, N.; Clanton, N.; Berkelhammer, L.; King, O.; Huling, A.; White, L.; Koch, J.; Okada, P.; Miles, D.; Raman, L.; Green, M.; Golson, E.; Jones, A.; Kelly, D.; Plumb, T.; Van de Bruinhorst, K.; Dowling, M.; Stavinoha, P.; Hernandez, A.; Wu, T.; Bauerfeld, C.; Rodkey, M.; Dibrell, H.; Atkinson, S.; O'Donnell, L.; Eubanks, J.; Loftis, L.; Castillo, L.; Graf, J.; Jaimon, N.; Kyle, U.; Henry, Y.; Dean, J. M.; Holubkov, R.; Browning, B.; Gildea, M.; Kuhn, R.; Register, K.; Tattersall, N.; Vrem, A.; Webster, A.; Clark, A.; Page, K.; Wang, J.; Herrera, L.; Yearley, J.; Enriquez, R.; Demarco, D.; Virtosu, M.; Su, S.; Bell, J.; Zuspan, S.; Burr, J.; Simmons, S.; McKean, V.; Traeden, C.; Nitsuma, H.; Bennett, K. S.; Lane, R.; Lilley, J.; Bjerregaard, S.; Jacobsen, K.; Watson, A.; Stephen, D.; DelaCruz, M.; Cooley, K.; Kwendakwema, N.; Ameel, B.; Jensen, G.; Metcalf, M.; Cole, R.; Moore, R.; Morita, D.; Burr, R.; Bennett, T.; Henricksen, J.; Hirshberg, E.; Hubbard, A.; Larsen, G.; Poss, B.; Schober, M.; Sweney, J.; Zimmerman, J.; McGuire, J.; Farris, R.; Yanay, O.; Reid, J.; Smith, L.; Brogan, T.; Hamilton, S.; Barker, R.; Greeley, C.; Greever, M. Sadler; Gospe, S.; Amlie-Lefond, C.; Breiger, D.; Paolozzi, A.; Berger, J.; Wessel, D.; Sharron, M.; Basu, S.; Wratney, A.; Dean, N.; Brown, K.; Reardon, J.; Tomanio, E.; Ramos, F.; Tadesse, B.; Menicucci, M.; Carpenter, J.; Swanson, S.; Brennan, T.; Glass, P.; Malek, B.; Mintz, M.; Meyer, M.; Wakeham, M.; Hanson, S.; Gorelick, Marc; Christensen, M.; Triscari, D.; Horn, B.; Murkowski, K.; Hecox, K.; Brosig, C.; THAPCA Trial Investigators
Loureiro, J. A.; Gomes, Bárbara; Fricker, Gert; Cardoso, I.; Ribeiro, C. A.; Gaiteiro, C.; Coelho, M. A. N.; Pereira, M. C.; Rocha, Sandra, 1975
Colloids and Surfaces B: Biointerfaces. 134:213-219
Electronic Resource
Academic Journal
Peixoto A; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Azevedo R; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Fernandes E; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007, Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Teixeira B; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Paulo P; Cancer Genetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072, Porto, Portugal.; Lima L; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-072, Porto, Portugal.; Health School of University Fernando Pessoa, 4249-004, Porto, Portugal.; Martins G; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-072, Porto, Portugal.; Oliveira MJ; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135, Porto, Portugal.; Institute for Biomedical Engineering (INEB), University of Porto, 4200-135, Porto, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007, Porto, Portugal.; Santos LL; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal.; Health School of University Fernando Pessoa, 4249-004, Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology, 4200-072, Porto, Portugal.; Porto Comprehensive Cancer Center (P.ccc), 4200-072, Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Research Center (CI-IPOP), Portuguese Institute of Oncology, 4200-072, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.; Porto Comprehensive Cancer Center (P.ccc), 4200-072, Porto, Portugal. jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Academic Journal
Fernandes E; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Freitas R; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Ferreira D; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Soares J; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Azevedo R; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Gaiteiro C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Peixoto A; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Oliveira S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Cotton S; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Relvas-Santos M; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Afonso LP; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Pathology Department, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Palmeira C; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Immunology Department, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Health Science Faculty, University of Fernando Pessoa, 4249-004 Porto, Portugal.; Oliveira MJ; Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.; Institute for Biomedical Engineering (INEB), Porto, Portugal, 4200-135 Porto, Portugal.; Ferreira R; REQUIMTE-LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.; Silva AMN; REQUIMTE-LAQV, Department of Chemistry and Biochemistry, Faculty of Sciences of the University of Porto, 4169-007 Porto, Portugal.; Lara Santos L; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Digestive Cancer Research Group, 1495-161 Algés, Portugal.; Health Science Faculty, University of Fernando Pessoa, 4249-004 Porto, Portugal.; Department of Surgical Oncology, Portuguese Institute of Oncology of Porto, 4200-162 Porto, Portugal.; Department, Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.; Ferreira JA; Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, 4200-162 Porto, Portugal.; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-013 Porto, Portugal.; Department, Porto Comprehensive Cancer Centre (P.ccc), 4200-162 Porto, Portugal.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Neves M; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Azevedo R; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Lima L; Portuguese Institute of Oncology, Porto, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Oliveira MI; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Peixoto A; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Ferreira D; Portuguese Institute of Oncology, Porto, Portugal.; Soares J; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Fernandes E; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Gaiteiro C; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Palmeira C; Portuguese Institute of Oncology, Porto, Portugal.; Cotton S; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal.; Mereiter S; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Campos D; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal.; Afonso LP; Portuguese Institute of Oncology, Porto, Portugal.; Ribeiro R; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; INEB-Institute for Biomedical Engineering of Porto, Portugal.; Fraga A; Hospital Centre- Hospital of Santo António of Porto, Portugal.; Tavares A; Portuguese Institute of Oncology, Porto, Portugal.; Mansinho H; Hemato-Oncology Clinic, Hospital Garcia de Orta, EPE, Almada, Portugal; Gupo de Investigação do Cancro Digestivo-GICD, Portugal.; Monteiro E; Portuguese Institute of Oncology, Porto, Portugal.; Videira PA; Glycoimmunology Group, UCIBIO, Departamento Ciências da Vida, Faculdade de Ciência e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal.; Freitas PP; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal; INESC - Microsistemas e Nanotecnologias, Lisboa, Lisbon, Portugal.; Reis CA; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal; Faculty of Medicine, University of Porto, Portugal.; Santos LL; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; UFP: School of Health Sciences, Fernando Pessoa University of Porto, Portugal; Porto Comprehensive Cancer Center (P.ccc), Porto, Portugal.; Dieguez L; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal.; Ferreira JA; Portuguese Institute of Oncology, Porto, Portugal; Institute of Biomedical Sciences Abel Salazar, University of Porto, Portugal; International Iberian Nanotechnology Laboratory (INL), Braga, Portugal; Glycobiology in Cancer, Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Portugal; Instituto de Investigação e Inovação em Saúde (I3S), University of Porto, Portugal. Electronic address: jose.a.ferreira@ipoporto.min-saude.pt.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101465345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4347 (Electronic) Linking ISSN: 18716784 NLM ISO Abbreviation: N Biotechnol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Gaiteiro, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어